BridgeBio Oncology Therapeutics
$9.08
5
-$0.52-5.42% 20:00 Today
+$0.00+0%20:00After hours
Statistics
Day High
9.78
Day Low
9.08
52W High
14.87
52W Low
7
Volume
201,092
Avg. Volume
389,662
Mkt Cap
727.98M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18NovExpected
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-49.62
-33.2
-16.79
-0.38
Expected EPS
-0.68682
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-134.04MNet Income
Analyst Ratings
24.75Average Price Target
The highest estimate is 29.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BBOT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Show more...
CEO
Pedro J. Beltran
Employees
88
Country
United States
ISIN
US1079241022
Listings
0 Comments
Share your thoughts
FAQ
What is BridgeBio Oncology Therapeutics stock price today?▼
The current price of BBOT is $9.08 USD — it has decreased by -5.42% in the past 24 hours. Watch BridgeBio Oncology Therapeutics stock price performance more closely on the chart.
What is BridgeBio Oncology Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange BridgeBio Oncology Therapeutics stocks are traded under the ticker BBOT.
What is BridgeBio Oncology Therapeutics market cap?▼
Today BridgeBio Oncology Therapeutics has the market capitalization of 727.98M
When is the next BridgeBio Oncology Therapeutics earnings date?▼
BridgeBio Oncology Therapeutics is going to release the next earnings report on November 18, 2026.
What were BridgeBio Oncology Therapeutics earnings last quarter?▼
BBOT earnings for the last quarter are -0.71 USD per share, whereas the estimation was -0.57 USD resulting in a -24.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BridgeBio Oncology Therapeutics revenue for the last year?▼
BridgeBio Oncology Therapeutics revenue for the last year amounts to 0 USD.
What is BridgeBio Oncology Therapeutics net income for the last year?▼
BBOT net income for the last year is -134.04M USD.
How many employees does BridgeBio Oncology Therapeutics have?▼
As of August 20, 2026, the company has 88 employees.
In which sector is BridgeBio Oncology Therapeutics located?▼
BridgeBio Oncology Therapeutics operates in the Health & Wellness sector.
When did BridgeBio Oncology Therapeutics complete a stock split?▼
BridgeBio Oncology Therapeutics has not had any recent stock splits.
Where is BridgeBio Oncology Therapeutics headquartered?▼
BridgeBio Oncology Therapeutics is headquartered in SOUTH SAN FRANCISCO, United States.